🔓 Unlock the full profile of Lucinda Quan (Aligos Therapeutics), including verified contact details, financial insights, and professional associations.
See Lucinda Quan Full Profile 💼 Explore Live Investment DealsFrom IPOs, Funding Rounds & M&A — See Who’s Behind Each Deal
Below are the ✅ Verified Contact Details to help you connect directly:
Email: luc*****@ali******.com
Mobile: 64777*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Lucinda Quan is currently serving as Co-Founder & Advisor at Aligos Therapeutics, with the role starting in January 2024.
- Prior to the current position, Lucinda Quan was the EVP, Chief Business Officer & General Counsel, Co-Founder at Aligos Therapeutics from April 2018 until December 2023, contributing significantly to the company’s strategic direction and legal frameworks.
- Aligos Therapeutics, founded in 2018, focuses on developing innovative therapeutics for viral infections and liver diseases, and is publicly traded under the symbol ALGS on the NASDAQ.
- Under Lucinda Quan's leadership, Aligos Therapeutics has seen an increase in workforce, reflecting a 7.25% growth over the past year.
- Lucinda Quan co-founded TCG Labs-Soleil, beginning in November 2023, and holds the position of Chief Operating Officer, indicating a strong commitment to advancing biotech and life sciences.
- Prior to Aligos Therapeutics, Lucinda Quan held key legal and business development roles at Merck, where she served as Executive Director for Transactions and Business Development, enhancing collaborative partnerships.
- Lucinda Quan's career includes a tenure as Vice President of Legal Affairs at Alios BioPharma, where contributions focused on legal oversight and strategic compliance.
- Lucinda Quan also held a role at InterMune as Vice President of Legal Affairs and Associate General Counsel, supporting the company's operational legal strategies.
- Aligos Therapeutics has a market cap of $29.8 million, and its mission to innovate in the biotechnology sphere reflects Lucinda Quan's impactful contributions to the field.